NCT00199030
Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath treatment 2 completed NCT02396043
Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma treatment 2 recruiting NCT00186875
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 2 completed NCT00199017
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults treatment 4 completed NCT06533748
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma treatment 2 not_yet_recruiting NCT02881086
Optimization of Therapy in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment treatment 3 active_not_recruiting NCT06289673
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma treatment 4 not_yet_recruiting NCT05602194
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma supportive_care 3 recruiting NCT06207123
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) treatment 1 / 2 recruiting NCT06514794
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy inT-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma treatment 2 not_yet_recruiting NCT02257684
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) treatment 2 terminated NCT04195633
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies treatment 2 recruiting NCT03571997
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma No drug interventions Not Available Not Available unknown_status NCT01614197
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma treatment 1 completed NCT01363128
Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma treatment 2 completed NCT00719888
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease treatment 2 active_not_recruiting NCT04984356
A Phase 1/2 Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL treatment 1 / 2 completed NCT01451515
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma treatment 2 completed NCT02290132
ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors Not Available Not Available unknown_status NCT01790152
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment No drug interventions Not Available Not Available recruiting NCT05476770
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies treatment 1 recruiting NCT00866749
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma treatment 2 completed NCT00949741
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients No drug interventions Not Available Not Available completed NCT03178617
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma No drug interventions supportive_care Not Available active_not_recruiting NCT02661035
Allo HSCT Using RIC for Hematological Diseases treatment 2 completed NCT04942730
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) treatment 2 completed NCT03314974
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders No drug interventions treatment 2 recruiting NCT02845882
LBL-2016 for Children or Adolescents in China treatment 3 active_not_recruiting NCT01761682
Acute Lymphoblastic Leukemia Registry at Asan Medical Center No drug interventions Not Available Not Available terminated NCT00199082
Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults treatment 4 completed NCT01177527
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders No drug interventions Not Available Not Available active_not_recruiting NCT03592576
Expanded Access to Navitoclax Not Available Not Available no_longer_available NCT02912676
Thiopurine EnhAnced Maintenance Therapy treatment 1 / 2 completed NCT05428176
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT05794880
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing No drug interventions treatment Not Available recruiting NCT01163201
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies treatment 1 / 2 withdrawn NCT02228772
Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults treatment 1 completed NCT06527781
A Study of PD5K3 in Healthy Adult Volunteers treatment 1 completed NCT01643408
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy treatment 2 completed NCT00412243
Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients treatment 1 / 2 completed NCT01513603
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia treatment 2 unknown_status NCT05885464
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) No drug interventions treatment 1 / 2 recruiting NCT02506933
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant supportive_care 2 active_not_recruiting NCT00587054
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders No drug interventions treatment 2 completed NCT04060277
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation supportive_care 2 active_not_recruiting NCT01910428
L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL treatment 1 terminated NCT00882011
Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters No drug interventions Not Available Not Available unknown_status NCT00195871
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma treatment 2 unknown_status NCT03792256
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) treatment 1 active_not_recruiting NCT01184885
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy treatment 0 completed NCT02220985
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD treatment 2 active_not_recruiting NCT04943952
JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase Not Available Not Available approved_for_marketing NCT06508099
Vitamin A and D Supplementation in Allogeneic HCT treatment 2 recruiting NCT02535806
Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults treatment 2 terminated NCT06477549
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT treatment 2 recruiting NCT01962636
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases treatment Not Available recruiting NCT02938741
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors treatment 4 unknown_status NCT01619124
Osteonecroses in Pediatric Patients With ALL No drug interventions Not Available Not Available unknown_status NCT03810196
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT No drug interventions treatment Not Available recruiting NCT01100658
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors treatment Not Available terminated NCT00187122
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma treatment Not Available completed NCT04666025
SARS-CoV-2 Donor-Recipient Immunity Transfer No drug interventions Not Available Not Available completed NCT03181126
A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma treatment 1 completed NCT01574274
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma treatment 2 active_not_recruiting NCT01943682
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma No drug interventions treatment 1 completed NCT01813344
Hyper-CVAD Treatment in Lymphoblastic Lymphoma No drug interventions Not Available Not Available unknown_status NCT03564704
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL treatment 2 / 3 unknown_status NCT03328104
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma treatment 1 completed NCT01842672
Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia treatment 1 / 2 completed NCT02419469
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma treatment 2 terminated NCT02960646
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies treatment 1 completed NCT03023046
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma treatment 2 completed NCT01474681
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies treatment 1 / 2 completed